Funded Tech Companies
Black Diamond Therapeutics
Black Diamond Therapeutics, based in Cambridge, received equity investments from Roche Venture Fund, Invus and BVF Partners.
Company Overview
Company Name
Black Diamond Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
139 Main St. 301
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Email Address
Company Background Information
Overview
Black Diamond Therapeutics (Nasdaq: BDTX): A Next-Wave Cancer Precision Medicine Company. Black Diamond Therapeutics has pioneered the development of selective medicines for patients with genetically-defined cancers driven by oncogenes activated by allosteric mutations.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/29/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Epstein
Chief Financial Officer
Thomas Leggett
Chief Operating Officer
Brent Hatzis-Schoch
Chief Scientific Officer
Christopher Roberts
Executive Vice President
Elizabeth Buck
Vice President
Tai-An Lin
Vice President
Matthew Lucas
Vice President
Nigel Waters
Vice President
Karsten Witt
Company Investors
- Roche Venture Fund
- Invus
- BVF Partners
- Deerfield Capital
- Boxer Capital
- Wellington Management Company
- New Enterprise Associates (Ali Behbahani)
- Nextech Invest
- City Hill Ventures
- Logos Capital
- Versant Ventures (Alex Mayweg)
- RA Capital (Rajeev Shah)
- Casdin Capital
- Perceptive Advisors
Browse more funded tech companies:
Black Diamond Advisory | Black Duck Software
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs